The effects of pharmacologic agents on myocardial sodium (Na+) and potassium (K+) stimulated ATPase.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects*; D002740:Chlorothiazide / Q000494:pharmacology; D004285:Dogs; D004976:Ethacrynic Acid / Q000494:pharmacology; D066298:In Vitro Techniques; D007511:Ischemia; D008274:Magnesium; D009206:Myocardium / Q000201:enzymology; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium; D011342:Procainamide / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D012964:Sodium
D010042:Ouabain; D002740:Chlorothiazide; D012964:Sodium; D011433:Propranolol; D000251:Adenosine Triphosphatases; D008274:Magnesium; D011802:Quinidine; D011342:Procainamide; D004976:Ethacrynic Acid; D011188:Potassium